- Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
-
Yim SY, Kim TH, Jun SS, Kim ES, Keum B, Seo YS, Yim HJ, Jeen YT, Chun HJ, Lee HS, Um SH, Kim CD, Won NH, Ryu HS
- KMID: 2412216
- Gut Liver.
- 2017 May;11(3):417-425.
- doi: 10.5009/gnl16148
BACKGROUND/AIMS: We aimed to clarify the association of hepatitis B surface antigen (HBsAg)/hepatitis B core antigen (HBcAg) with the disease status and treatment response in patients with chronic hepatitis B... -
- CITED
-
- Close
- SHARE
-
- Close
- Circulating immune complexes and cell-mediated immunity in patients with hepatitis B virus associated liver diseases
-
Kim SA, Lee SI, Choi IH, Shin JS, Uhm JR, Kim SJ, Choi HJ
- KMID: 1729582
- Yonsei Med J.
- 1990 Dec;31(4):347-358.
- doi: 10.3349/ymj.1990.31.4.347
The prevalence of circulating immune complexes (CIC), their role and their relationship to cell-mediated immunity in patients with hepatitis B virus associated liver disease are still controversial. This study was... -
- CITED
-
- Close
- SHARE
-
- Close
